VIRACTA THERAPEUTICS, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 13th, 2021 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledJanuary 13th, 2021 Company Industry JurisdictionThis Executive Employment Agreement (this “Agreement”) is entered into as of February 26, 2020, and becomes effective upon Dr. Lisa Rojkjaer’s first date of employment, provided such date occurs on or before May 1, 2020, (the “Effective Date”) by and between Viracta Therapeutics, Inc. (the “Company”), and Dr. Lisa Rojkjaer (“Executive”).
VIRACTA THERAPEUTICS, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 13th, 2021 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledJanuary 13th, 2021 Company Industry JurisdictionThis Executive Employment Agreement (this “Agreement”) is entered into as of July 29, 2019, (the “Effective Date”) by and between Viracta Therapeutics, Inc. (the “Company”), and Daniel R. Chevallard, CPA (“Executive”).